Earnings Call Webcast February 7, 2025 Mettler-Toledo International Inc. Q4 2024 Financial Results Sales by Geography Safe Harbor Statement 2 Statements in this presentation which are not historical facts constitute "forward looking statements" within the meaning of Section 27A of the U.S. Securities Act of 1933 and Section 21E of the U.S. Securities Exchange Act of 1934. These statements involve known and unknown risks, uncertainties and other factors that may cause our or our businesses, actual results, l ...

Financial Data and Key Metrics Changes - Sales in Q4 were $1,045 million, representing a 12% increase in local currency and U.S. dollars [9] - Adjusted EPS for the quarter was $12.41, a 32% increase over the prior year [15] - Gross margin was 61.2% in the quarter, an increase of 220 basis points due to higher volume and positive price realization [13] Business Line Data and Key Metrics Changes - Laboratory sales increased 18% in Q4, while industrial sales grew 8% [11] - For the full year 2024, laboratory sales increased 6%, and industrial sales increased 1% [12] - Food retail declined 14% in Q4 and 14% for the full year [12][16] Market Data and Key Metrics Changes - Local currency sales grew 7% in The Americas, 19% in Europe, and 14% in Asia Rest of World for Q4 [10] - Local currency sales in China decreased 11% for the full year [11] - Excluding shipping delays, local currency sales in 2024 were flat, with a 1% growth in The Americas and a 2% growth in Europe [11] Company Strategy and Development Direction - The company aims to drive growth in 2025 by focusing on automation, digitalization, and high-growth areas [9] - Continued investment in innovation and service sales is a priority to enhance market leadership [28] - The company is implementing new strategies with Spinnaker 6 and Blue Ocean programs to improve operational excellence and customer experience [27][29] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about gradual market improvement in 2025 despite uncertainties in core markets [17][26] - The company remains cautious regarding the geopolitical situation and its potential impact on operations, particularly in China [37][39] - Management noted that customer demand in pharma and biopharma has improved, contributing to growth [24][93] Other Important Information - Adjusted free cash flow amounted to $900.6 million in 2024, a 2% increase on a per-share basis from 2023 [16] - The company expects local currency sales to decline by approximately 3% to 4% in Q1 2025, with adjusted EPS projected to be in the range of $7.75 to $7.95 [19] Q&A Session Summary Question: What is the outlook for Q1 performance given the Q4 results? - Management indicated that while Q4 showed strong results, they expect a slower start to 2025, with underlying growth potentially in the mid-single digits for Q1 [31][36] Question: How does the competitive landscape in China look? - Management noted that they have a strong presence in China with local R&D and manufacturing, which mitigates some risks associated with local competition [38][39] Question: What is the outlook for the industrial business? - Management remains cautious about the core industrial segment, expecting low single-digit growth, while product inspection is anticipated to perform better [45][46] Question: How are tariffs impacting the business? - Management has incorporated potential tariff impacts into their guidance and is prepared to adjust pricing and supply chain strategies accordingly [71][95] Question: What are the assumptions for growth in the lab segment? - Management expects low to mid-single-digit growth for the lab segment in 2025, with a stronger performance anticipated in the second half of the year [50][94]

Core Insights - Mettler-Toledo reported quarterly earnings of $12.41 per share, exceeding the Zacks Consensus Estimate of $11.69 per share, and showing an increase from $9.40 per share a year ago, resulting in an earnings surprise of 6.16% [1] - The company achieved revenues of $1.05 billion for the quarter ended December 2024, surpassing the Zacks Consensus Estimate by 3.51% and up from $934.99 million year-over-year [2] - Mettler-Toledo has consistently outperformed consensus EPS and revenue estimates over the last four quarters [2] Earnings Outlook - The sustainability of Mettler-Toledo's stock price movement will largely depend on management's commentary during the earnings call and future earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $8.06 on revenues of $929.46 million, while for the current fiscal year, it is $41.94 on revenues of $3.94 billion [7] Industry Context - The Medical - Instruments industry, to which Mettler-Toledo belongs, is currently ranked in the top 34% of over 250 Zacks industries, indicating a favorable outlook compared to the bottom 50% [8] - The performance of Mettler-Toledo's stock may also be influenced by the overall industry outlook, as empirical research shows a strong correlation between stock movements and earnings estimate revisions [5][8] Competitor Insights - Edwards Lifesciences, another company in the same industry, is expected to report quarterly earnings of $0.55 per share, reflecting a year-over-year decline of 14.1%, with revenues anticipated to be $1.36 billion, down 11.2% from the previous year [9][10]

Core Insights - Mettler-Toledo (MTD) is expected to report quarterly earnings of $11.69 per share, reflecting a 24.4% increase year-over-year, with revenues projected at $1.01 billion, an 8% increase from the previous year [1] - The consensus EPS estimate has been revised 1.5% lower in the last 30 days, indicating a reevaluation by analysts [1][2] - Analysts have provided various estimates for Mettler-Toledo's key metrics, which can offer a more comprehensive view of the company's performance [3] Revenue Estimates - Analysts forecast 'Net sales- Products' to reach $776.33 million, indicating a 9.5% increase from the prior-year quarter [4] - 'Net sales- Service (Point in Time+Over Time)' is expected to be $232.69 million, reflecting a 3% increase year-over-year [4] - 'Net sales- Retail' is projected to decline to $46.93 million, suggesting an 8.7% decrease from the previous year [4] Additional Sales Projections - 'Net sales- Industrial' is anticipated to reach $393.45 million, marking a 6.2% increase from the year-ago quarter [5] - 'Net sales- Laboratory' is expected to be $568.55 million, indicating a 10.8% increase year-over-year [5] - Over the past month, Mettler-Toledo shares have gained 10.2%, outperforming the Zacks S&P 500 composite's 2.7% increase [5]

Nearly two years ago, back in July of 2023, one company that I ended up rating a 'hold' was Mettler-Toledo International (NYSE: MTD ). This is an enterprise that focuses on producing and selling precision instruments and thatCrude Value Insights offers you an investing service and community focused on oil and natural gas. We focus on cash flow and the companies that generate it, leading to value and growth prospects with real potential.Subscribers get to use a 50+ stock model account, in-depth cash flow ana ...

Equity strategist [Bernard Holdings]. Objective view on the directional bias of markets. Technical expertise bridges the complex relationships between value drivers, capital flows and price action. Partners are represented over the cross-section of financial markets, from speculators, hedgers, long-term traders and the public. Research covers investment securities and futures & options markets. Shoot me a message to talk trade ideas or portfolio construction. Disclaimer:All research is strictly for informat ...

Core Viewpoint - Mettler-Toledo International (MTD) experienced a 7.19% decline in share price following the release of its third-quarter 2024 results, despite reporting adjusted earnings and net sales that exceeded consensus estimates [1][2]. Financial Performance - MTD reported adjusted earnings of $10.21 per share, beating the Zacks Consensus Estimate by 2.1%, and reflecting a year-over-year increase of 4.2% [1]. - Net sales reached $954.5 million, surpassing the Zacks Consensus Estimate of $942 million, with a reported increase of 1.3% and a local currency increase of 1% compared to the previous year [1][3]. Segment Performance - Revenue breakdown for the third quarter included: Laboratory Instruments at $534.8 million (56% of net sales), Industrial Instruments at $365.5 million (38.3%), and Food Retail at $54.2 million (5.7%) [3]. - The Laboratory segment grew by 5% year-over-year, while the Industrial and Food Retail segments remained flat, with the Food Retail segment declining by 20% on a local currency basis [3]. Geographic Performance - Sales distribution was as follows: Americas at $393.6 million (41.2% of net sales), Europe at $260 million (27.2%), and Asia/Rest of World at $300.9 million (31.5%) [4]. - Year-over-year sales growth in Europe and Asia/Rest of World was 1% and 4% respectively, while sales in the Americas decreased by 1% [4]. Operating Results - MTD's gross margin was reported at 60%, an increase of 60 basis points year-over-year [5]. - Research & Development (R&D) expenses were $47.1 million, up 2.1% from the previous year, while Selling, General & Administrative (SG&A) expenses rose by 5.2% to $228.8 million [5]. - The adjusted operating margin contracted by 30 basis points to 31.1% compared to the prior year [6]. Balance Sheet & Cash Flow - As of September 30, 2024, Mettler-Toledo had cash and cash equivalents of $71.6 million, an increase from $70.8 million as of June 30, 2024 [7]. - Long-term debt rose to $1.89 billion from $1.75 billion, while cash generated from operating activities was $254.7 million, slightly down from $257.5 million in the previous quarter [7]. Guidance - For Q4 2024, Mettler-Toledo expects sales to increase by 8% in local currency compared to the previous year, with a consensus estimate of $1.01 billion [9]. - Adjusted earnings are projected to be between $11.63 and $11.78 per share, indicating a growth of 24-25% year-over-year [9]. - For the full year 2024, sales in local currency are anticipated to rise by 2%, with a consensus estimate of $3.83 billion, reflecting a year-over-year increase of 0.98% [10][11].

Financial Data and Key Metrics Changes - Sales for Q3 2024 were $954.5 million, representing a 1% increase in both local currency and U.S. dollars [9] - Gross margin increased by 60 basis points to 60%, driven by positive price realization and benefits from the SternDrive program [12] - Adjusted EPS for the quarter was $10.21, a 4% increase over the prior year, while reported EPS was $9.96 compared to $9.21 in the prior year [14] Business Line Data and Key Metrics Changes - Laboratory sales increased by 5% in Q3, while Industrial sales were flat, with core Industrial down 1% and product inspection up 1% [11] - Food Retail sales declined by 20% in Q3 compared to significant project activity last year [11] - Year-to-date, Laboratory sales increased by 2%, while Industrial decreased by 2%, with Food Retail down 14% [12] Market Data and Key Metrics Changes - Local currency sales grew 1% in Europe, declined 1% in the Americas, and grew 4% in Asia/Rest of the World for Q3 [9] - Year-to-date local currency sales decreased by 15% in China [10] - Sales in China returned to growth in Q3, but underlying demand remained soft due to weak economic growth [31] Company Strategy and Development Direction - The company is focused on leveraging business diversity and innovation to capture growth opportunities and gain market share [8] - Investments in automation, digitalization, and service expansion are key components of the company's growth strategy [17][34] - The company aims to grow its Service business, which represents approximately 25% of sales and has grown 7% year-to-date [35] Management's Comments on Operating Environment and Future Outlook - Management noted that market conditions remain soft, particularly in China, but expect gradual improvement throughout 2025 [17] - The company anticipates local currency sales growth of approximately 8% for Q4 2024, benefiting from prior-year shipping delays [19] - For 2025, local currency sales are expected to increase approximately 3%, with adjusted EPS forecasted to be in the range of $41.85 to $42.50 [20][21] Other Important Information - Adjusted free cash flow for the first nine months was $671 million, a 7% increase on a per-share basis [16] - The company plans to make targeted investments in innovation and service to strengthen competitive advantages [33] Q&A Session Summary Question: What are the assumptions for Labs versus Industrials in fiscal '25? - Management expects Services to continue growing in the mid- to high single digits, while Labs are projected to grow low to mid-single digits on a reported basis [44][45] Question: What is the outlook for operating margin expansion for fiscal '25? - Operating margin is expected to be flattish to slightly up, with Service margins above corporate average [47] Question: How is the company preparing for potential changes in the tariff environment? - The company has expanded its production footprint globally, including in Mexico, to provide more manufacturing flexibility [70][71] Question: What are the growth expectations for the Process Analytics business? - The Process Analytics business has returned to solid growth, with destocking behind the company [73] Question: What are the assumptions for Q4 growth by segment and geography? - For Q4, Lab is expected to be up low double digits, while core Industrial is expected to be up low single digits [90]

Company Performance - Mettler-Toledo reported quarterly earnings of $10.21 per share, exceeding the Zacks Consensus Estimate of $10 per share, and up from $9.80 per share a year ago, representing an earnings surprise of 2.10% [1] - The company posted revenues of $954.54 million for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 1.34%, compared to $942.46 million in the same quarter last year [2] - Over the last four quarters, Mettler-Toledo has surpassed consensus EPS estimates three times and topped consensus revenue estimates three times [2] Stock Performance - Mettler-Toledo shares have increased approximately 15.3% since the beginning of the year, while the S&P 500 has gained 24.3% [3] - The current consensus EPS estimate for the upcoming quarter is $11.81 on revenues of $1.01 billion, and for the current fiscal year, it is $40.34 on revenues of $3.83 billion [7] Industry Outlook - The Instruments - Scientific industry, to which Mettler-Toledo belongs, is currently ranked in the bottom 10% of over 250 Zacks industries, indicating potential challenges ahead [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Mettler-Toledo's stock performance [5][6]

FOR IMMEDIATE RELEASE Exhibit 99.1 METTLER-TOLEDO INTERNATIONAL INC. REPORTS THIRD QUARTER 2024 RESULTS COLUMBUS, Ohio, USA – November 7, 2024 – Mettler-Toledo International Inc. (NYSE: MTD) today announced third quarter results for 2024. Provided below are the highlights: • Reported and local currency sales increased 1% compared with the prior year. • Net earnings per diluted share as reported (EPS) were $9.96, compared with $9.21 in the prior-year period. Adjusted EPS was $10.21, an increase of 4% over th ...